000			02243 a2200589 4500
005			20250518071238.0
264		0	_c20200504
008			202005s 0 0 eng d
022			_a1522-1547
024	7		_a10.1152/ajpgi.00130.2019 _2doi
040			_aNLM _beng _cNLM
100	1		_aJamshed, Muhammad Babar
245	0	0	_aAntitumor activity and combined inhibitory effect of ceritinib with gemcitabine in pancreatic cancer. _h[electronic resource]
260			_bAmerican journal of physiology. Gastrointestinal and liver physiology _c01 2020
300			_aG109-G119 p. _bdigital
500			_aPublication Type: Comparative Study; Journal Article; Research Support, Non-U.S. Gov't
650	0	4	_aAnaplastic Lymphoma Kinase _xantagonists & inhibitors
650	0	4	_aAnimals
650	0	4	_aAntineoplastic Combined Chemotherapy Protocols _xpharmacology
650	0	4	_aApoptosis _xdrug effects
650	0	4	_aAutophagy _xdrug effects
650	0	4	_aCell Line, Tumor
650	0	4	_aCell Movement _xdrug effects
650	0	4	_aCell Proliferation _xdrug effects
650	0	4	_aCell Size _xdrug effects
650	0	4	_aDeoxycytidine _xanalogs & derivatives
650	0	4	_aDrug Resistance, Neoplasm
650	0	4	_aExtracellular Signal-Regulated MAP Kinases _xmetabolism
650	0	4	_aHumans
650	0	4	_aMale
650	0	4	_aMice, Inbred BALB C
650	0	4	_aMice, Nude
650	0	4	_aPancreatic Neoplasms _xdrug therapy
650	0	4	_aProtein Kinase Inhibitors _xpharmacology
650	0	4	_aProto-Oncogene Proteins c-akt _xmetabolism
650	0	4	_aPyrimidines _xpharmacology
650	0	4	_aSTAT3 Transcription Factor _xmetabolism
650	0	4	_aSignal Transduction
650	0	4	_aSulfones _xpharmacology
650	0	4	_aXenograft Model Antitumor Assays
650	0	4	_aGemcitabine
700	1		_aMunir, Fahad
700	1		_aShahid, Numan
700	1		_aSadiq, Ussama
700	1		_aMuhammad, Syed Aun
700	1		_aGhanem, Noor Bader
700	1		_aZhong, Hong
700	1		_aLi, Xiaokun
700	1		_aZhang, Qiyu
773	0		_tAmerican journal of physiology. Gastrointestinal and liver physiology _gvol. 318 _gno. 1 _gp. G109-G119
856	4	0	_uhttps://doi.org/10.1152/ajpgi.00130.2019 _zAvailable from publisher's website
999			_c30321944 _d30321944